S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
LON:ABDX

Abingdon Health (ABDX) Share Forecast, Price & News

GBX 10
-0.25 (-2.44%)
(As of 06/8/2023 ET)
Compare
Today's Range
9.56
10.50
50-Day Range
5.98
13
52-Week Range
3.60
15.39
Volume
249,485 shs
Average Volume
417,894 shs
Market Capitalization
£12.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ABDX stock logo

About Abingdon Health (LON:ABDX) Stock

Abingdon Health Plc engages in the development, manufacture, and distribution of diagnostic devices worldwide. The company offers AbC-19 Rapid Test, a COVID-19 IgG rapid antibody test; nucleic acid lateral flow immunoassays; PCRD and PCRD FLEX, nucleic acid lateral flow tests used for rapid readouts post isothermal amplification; Abingdon Simply Test, a range of self-tests; and 2019-nCoV Antigen Test, a rapid lateral flow test for the qualitative detection of antigens to SARS-CoV-2. It also provides AppDx, a customizable image capturing technology that transforms a smartphone into a self-sufficient and standalone lateral-flow reader. In addition, the company provides contract manufacturing, nucleic acid lateral flow test customization, and lateral flow development and manufacturing services. Further, it provides consultancy services to businesses in the healthcare technology sector. The company has a collaboration and co-marketing agreement with Abcam plc. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

Receive ABDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abingdon Health and its competitors with MarketBeat's FREE daily newsletter.

ABDX Stock News Headlines

NOTICE: Your retirement is in immediate danger
Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>
Opening date for new Aldi store in Abingdon
Abingdon Health Plc (ABDX.L)
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Abingdon Health boosted by positive update on antigen test
3 of the best penny stocks to buy in October
Abingdon Healt. Share Chat
Abingdon Health Plc (ABDX)
See More Headlines

ABDX Price History

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
123
Year Founded
N/A

Profitability

Net Income
£-17,950,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£2.24 million
Cash Flow
GBX 4.67 per share
Book Value
GBX 1 per share

Miscellaneous

Free Float
N/A
Market Cap
£12.78 million
Optionable
Not Optionable
Beta
0.33

Key Executives

  • Mr. Chris Henry Francis Yates (Age 48)
    CEO & Director
    Comp: $222k
  • Ms. Melanie Ross (Age 42)
    CFO, Company Sec. & Director
    Comp: $166k
  • Mr. Mark Jones
    Chief Operating Officer
  • Ms. Brenda Hogan
    HR Director
  • Mr. Oliver Gardner
    Chief Commercial Officer
  • Ms. Nina Garrett
    Head of Assay Devel.













ABDX Stock - Frequently Asked Questions

How have ABDX shares performed in 2023?

Abingdon Health's stock was trading at GBX 6.50 at the beginning of 2023. Since then, ABDX shares have increased by 61.5% and is now trading at GBX 10.50.
View the best growth stocks for 2023 here
.

What is Abingdon Health's stock symbol?

Abingdon Health trades on the London Stock Exchange (LON) under the ticker symbol "ABDX."

How do I buy shares of Abingdon Health?

Shares of ABDX stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Abingdon Health's stock price today?

One share of ABDX stock can currently be purchased for approximately GBX 10.50.

How much money does Abingdon Health make?

Abingdon Health (LON:ABDX) has a market capitalization of £12.78 million and generates £2.24 million in revenue each year. The company earns £-17,950,000.00 in net income (profit) each year or GBX (0.06) on an earnings per share basis.

How many employees does Abingdon Health have?

The company employs 123 workers across the globe.

How can I contact Abingdon Health?

The official website for the company is www.abingdonhealth.com. The company can be reached via phone at 44 19 0440 6082.

This page (LON:ABDX) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -